BridgeBio Oncology Therapeutics BBOT
NASDAQ BBOT
$2.78 +0.06 (+2.21%)
As of: Oct 21, 2026 · 1:58 PM EDT

BridgeBio Oncology Therapeutics (BBOT) Other Non-Current Liabilities (2024)

Updated

BridgeBio Oncology Therapeutics (BBOT) recorded Other Non-Current Liabilities of $5.52 million in Q1 2024.

Analysis

BridgeBio Oncology Therapeutics (BBOT) Other Non-Current Liabilities (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,134.24 Bn 1,102.83 Bn 19.71 Bn
2 Johnson & Johnson 616.11 Bn 534.64 Bn 17.26 Bn
3 AbbVie 501.21 Bn 474.32 Bn 12.70 Bn
4 Merck 367.51 Bn 321.89 Bn 12.21 Bn
5 Novartis Ag 297.95 Bn 261.94 Bn 11.24 Bn
6 Astrazeneca 261.35 Bn 235.03 Bn 12.86 Bn
7 Amgen 235.88 Bn 191.28 Bn 7.24 Bn
8 Gilead Sciences 190.74 Bn 164.94 Bn 6.22 Bn
9 Pfizer 169.40 Bn 116.05 Bn 10.94 Bn
10 BridgeBio Oncology Therapeutics 223.75 Mn -1.15 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 5.52 Mn
API Access

BridgeBio Oncology Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=BBOT&period=max&api_key=YOUR_API_KEY